Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $7.13B | $45.37 | $40.00 | -11.84% | Buy | 3 | 41.64% | 149.97% | 252.17% | 97.07% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.13B | $8.20 | N/A | N/A | N/A | N/A | 24.09% | 213.21% | 64.76% | 44.40% | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.54B | $71.48 | $143.25 | 100.41% | Strong Buy | 4 | 28.82% | 52.97% | 116.05% | 93.82% | |||
| KRYS | KRYSTAL BIOTECH INC | $4.77B | $165.69 | $226.60 | 36.76% | Strong Buy | 5 | 39.30% | 59.00% | 43.95% | 39.40% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $587.79M | $7.56 | $9.03 | 19.48% | Strong Buy | 3 | 20.03% | 35.96% | 45.54% | 30.75% | |||
| SPRY | ARS PHARMACEUTICALS INC | $1.39B | $14.16 | $28.33 | 100.09% | Strong Buy | 3 | 59.45% | 56.74% | 56.68% | 41.45% | |||
| GYRE | GYRE THERAPEUTICS INC | $874.34M | $9.34 | N/A | N/A | N/A | N/A | 49.51% | 132.23% | 428.74% | 216.48% | |||
| ARGX | ARGENX SE | $38.88B | $639.90 | $740.71 | 15.75% | Strong Buy | 14 | 973.96% | 24.89% | 38.84% | 34.43% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.95B | $24.27 | $33.20 | 36.79% | Strong Buy | 5 | 14.80% | 21.62% | 44.40% | 37.94% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.71B | $29.86 | $53.40 | 78.83% | Strong Buy | 5 | 17.48% | 25.67% | 55.91% | 36.88% | |||
| VCEL | VERICEL CORP | $1.89B | $37.92 | $61.80 | 62.97% | Strong Buy | 5 | 25.85% | 79.15% | 33.55% | 22.63% | |||
| EXEL | EXELIXIS INC | $10.88B | $38.89 | $37.81 | -2.77% | Buy | 16 | 10.49% | 22.79% | 59.24% | 45.10% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $6.09B | $62.78 | $129.39 | 106.09% | Buy | 13 | 30.93% | 83.31% | 87.92% | 33.89% | |||
| HALO | HALOZYME THERAPEUTICS INC | $7.39B | $60.03 | $63.00 | 4.95% | Buy | 5 | 19.42% | 29.99% | 297.54% | 52.46% | |||
| RIGL | RIGEL PHARMACEUTICALS INC | $334.39M | $18.72 | $36.80 | 96.58% | Buy | 5 | 12.31% | 31.54% | 1,733.05% | 34.75% | |||
| RPRX | ROYALTY PHARMA PLC | $18.72B | $32.48 | N/A | N/A | N/A | N/A | 19.38% | 62.41% | 30.52% | 17.32% | |||
| NVO | NOVO NORDISK A S | $292.90B | $65.60 | $112.00 | 70.73% | Buy | 2 | 15.61% | 19.64% | 127.89% | 39.40% | |||
| ADMA | ADMA BIOLOGICS INC | $5.53B | $23.27 | $25.33 | 8.87% | Strong Buy | 3 | 20.25% | 10.07% | 98.04% | 70.02% | |||
| INCY | INCYTE CORP | $12.01B | $62.03 | $73.50 | 18.49% | Hold | 10 | 8.54% | 197.25% | 47.45% | 30.27% | |||
| MDXG | MIMEDX GROUP INC | $933.48M | $6.32 | $13.00 | 105.70% | Strong Buy | 1 | 11.95% | 36.78% | N/A | N/A | |||
| MNKD | MANNKIND CORP | $1.50B | $4.95 | $9.50 | 91.92% | Strong Buy | 2 | 15.08% | 46.28% | -173.34% | 34.69% | |||
| VCYT | VERACYTE INC | $2.32B | $29.71 | $42.00 | 41.37% | Buy | 8 | 10.44% | 71.34% | 7.69% | 6.95% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.96B | $62.71 | $95.22 | 51.85% | Buy | 9 | 10.04% | 32.25% | N/A | N/A | |||
| GNFT | GENFIT SA | $203.98M | $4.08 | $13.00 | 218.63% | Buy | 1 | -2.57% | 77.90% | -55.93% | -25.57% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.12B | $117.18 | $188.67 | 61.01% | Strong Buy | 12 | 5.50% | 31.52% | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $7.85B | $49.63 | $78.83 | 58.84% | Buy | 6 | 5.97% | 39.71% | N/A | N/A | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.43B | $14.57 | $23.86 | 63.74% | Buy | 7 | 10.44% | 4.72% | 50.55% | 31.19% | |||
| GMAB | GENMAB A | $13.85B | $20.93 | $39.25 | 87.53% | Strong Buy | 4 | 18.35% | 12.82% | 4.49% | 3.60% | |||
| UTHR | UNITED THERAPEUTICS CORP | $13.25B | $293.85 | $371.00 | 26.25% | Buy | 6 | 5.18% | 1.11% | 22.45% | 19.74% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $63.70B | $590.00 | $840.33 | 42.43% | Buy | 18 | 5.84% | 0.85% | 21.93% | 17.16% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.